What is ProMedTek?
ProMedTek is a mission-driven medical device company focused on enhancing the quality of life for veterans and active military personnel. Its core offering is the proprietary Replexa+ therapy system, an FDA-cleared device employing thermal shortwave diathermy technology. This system is designed to alleviate pain, reduce muscle spasms, and improve mobility across various body parts, positioning ProMedTek as a key player in pain management solutions. The company also actively engages with the community through partnerships with veteran and military support organizations.
How much funding has ProMedTek raised?
ProMedTek has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in ProMedTek
PPP
Public-Private Partnership
What's next for ProMedTek?
With its large-scale late-stage funding and a recent major strategic investment, ProMedTek is poised for significant expansion and development. The substantial capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and broaden the market reach of the Replexa+ therapy system. This strategic backing suggests a clear trajectory towards scaling operations and solidifying its market position, particularly within the veteran and military healthcare sectors. Future growth will likely involve expanding treatment applications and strengthening its network of community partnerships.
See full ProMedTek company page
